Buried Treasure: The Stealth Issue of E-Business Taxation
It}s generally accepted that pharmaceutical companies need to transform their business processes to remain competitive in the global economy. Shareholders, analysts, partners, suppliers, and customers consistently applaud announcements about information technology (IT) improvements. But managing the necessary changes to exploit the value of e-business initiatives is more problematic than many companies realize, requiring a focused management effort, within which is buried the stealth issue of e-business taxation.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
